Tosylchloramide

Tosylchloramide

SCHEMBL14764474

Cc1ccc(S(=O)(=O)NCl)cc1.Cc1ccc(S(=O)(=O)NCl)cc1.[NaH]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
MMP1 P03956 1/20 0.59
MMP2 P08253 1/20 0.59
MMP9 P14780 1/20 0.59
MMP8 P22894 1/20 0.59
MMP13 P45452 1/20 0.59
ALDH1A1 P00352 7/20 0.55
KDM4E B2RXH2 3/20 0.53
HPGD P15428 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
CYP2C9 P11712 3/20 0.53
CYP2C19 P33261 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2D6 P10635 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tosylchloramide SCHEMBL14764471 1.00 GAA (0.61) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL28882248 1.00 GAA (0.61) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL567565 1.00 GAA (0.61) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL10526373 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL696560 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL6009520 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL8154955 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL3615720 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL7225596 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1
Tosylchloramide SCHEMBL10424726 0.98 GAA (0.59) GAASMN1; SMN2CA1CA2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014139983-A1 [1,2,4]TRIAZOLO[4,3-A]QUINOXALINES AS DUAL PDE2/PDE10 INHIBITORS H. LUNDBECK A/S (DK) 2014-09-18 WO disclosed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed